CURRENT VIEWS ON ABDOMINAL ADHESIONS IN TUBOPERITONEAL INFERTILITY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. One of the main causes of infertility is small pelvic adhesions that are induced by a set of various factors and result in tuboperitoneal infertility. Case description. The paper describes the experience in choosing combination therapy for a patient with obstruction of both fallopian tubes after laparoscopic salpingolysis. Pregnancy was recorded 3 months after treatment. Conclusion. It is necessary to perform combination therapy for inflammatory diseases and conditions in the period after surgery using drugs that can reduce the formation of adhesions in the small pelvis. For this purpose, longidase can be considered as the drug of choice.

Full Text

Restricted Access

About the authors

Lyudmila E. Smirnova

PhD, Department of Obstetrics and Gynecology, Assistant Faculty of Dentistry, MSMSU. 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1

Madina M. Umakhanova

MD, Professor of Obstetrics and Gynecology, Faculty of Dentistry, MSMSU 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1

Amirhan M. Torchinov

MD, professor, Department of Obstetrics and Gynecology, Faculty of Dentistry, MSMSU. 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1

References

  1. Балан В.Е., Журавель А.С. Возможности применения препаратов, содержащих гиалуроновую кислоту в гинекологии. Эффективная фармакотерапия. 2014; 23: 50-5. [Balan V.E., Zhuravel A.S. The possibilities of application of preparations containing hyaluronic acid in gynecology. Effektivnaya farmakoterapiya. 2014; 23: 50-5.
  2. Пахилова Е.В., Синчихин С.П., Мамиев О.Б., Буров А.В. Некоторые современные аспекты этиологии, клинической картины и лечения острых воспалительных заболеваний придатков матки. Гинекология. 2010; 12(5): 20-4. [Pakhilova E.V., Sinchikhin S.P., Mamiev O.B., Burov A.V. Some modern aspects of etiology, clinical presentation, and treatment of acute inflammatory diseases of the uterus. Ginekologiya. 2010; 12(5): 20-4.
  3. Прилепская В.Н., Яглов В.В. Воспалительные заболевания органов малого таза. М.: ГЭОТАР-Медиа; 2010. [Prilepskaya V.N., Yaglov V.V. Inflammatory diseases of the pelvic organs. Moscow: GEOTAR-Media; 2010.
  4. Петрович Е.А., Колесов А.А., Манухин И.Б. Безопасность и эффективность препарата Лонгидазы 3000 МЕ при лечении больных, страдающих спаечным процессом в малом тазе. Иммунология. 2006; 27(2): 124-6. [Petrovich E.A., Kolesov A.A., Manuhin I.B. The safety and efficacy of the drug Longidaza 3000 IU for the treatment of patients with adhesive process in small pelvis. Immunologiya. 2006; 27(2): 124-6.
  5. Ковалева Л.А. Возможности ферментной терапии при хронических воспалительных заболеваниях органов малого таза. Русский медицинский журнал. 2010; 18(19): 1162-4. [Kovaleva L.A. The possibilities of enzyme therapy for chronic inflammatory diseases of the pelvic organs. Russkiy meditsinskiy zhurnal. 2010; 18(19): 1162-4.
  6. Некрасов А.В., Пучкова Н.Г., Карапутадзе Н.Т. Физико-химические принципы создания Лонгидазы. Иммунология. 2006; 27(2): 114 8 [Nekrasov A.V., Puchkova N.G., Karaputadze N.T. Physico-chemical principles of Longidaza creation. Immunologiya. 2006; 27(2): 114-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies